Summary
(+)-N-Propargyl-1-aminoindan (rasagiline) and a series of derivatives have been synthesized and screened for monoamine oxidase inhibitory activity. Rasagiline and several analogues were found be highly selective and potent inhibitors of the B form of the enzyme in contrast to the levorotatory enantiomer which was not active. The results indicate that rasagiline has potential for the treatment of Parkinson’s Disease. This compound is currently under development for that indication.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Birkmayer W, Riederer P, Youdim MBH, Linauer W (1975) Potentiation of antiakinetic effect after L-dopa treatment by an inhibitor of MAO-B, l-deprenyl. J Neural Transm 36: 303–323
Engberg G, Elebring T, Nissbrandt H (1991) Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites. J Pharmacol Exp Ther 259: 841–847
Finberg JPM, Tenne M, Youdim MBH (1981) Tyramine antagonistic properties of AGN-1135, an irreversible inhibitor of monoamine oxidase type B. Br J Pharmacol 73: 65–74
Ghislandi V, Vercesi D (1976) Scissione ottica E configurazione dell’1-aminobenzociclobutaene e dell’1-aminoindano. Boll Chim Farm 115: 489–500
Hazelhoff B, De Vries J, Dijkstra D, de Jong W, Horn A (1985) The neuro-pharmacological profile of N-Methyl-N-propargyl-2-aminotetralin. Naunyn Schmiedebergs Arch Pharmacol 330: 50–59
Kalir A, Sabbagh A, Youdim MBH (1981) Selective acetylenic “suicide” and reversible inhibitors of monoamine oxidase types A and B. Br J Pharmacol 73: 55–64
Martin Y, Martin W, Taylor J (1975) Regression analysis of the relationship between physical properties and the in vitro inhibition of monoamine oxidase by propynylamines. J Med Chem 18: 883–888
O’Carrol AM, Fowler CJ, Philips JP, Tobbia I, Tipton KF (1983) The deamination of dopamine by human brain monoamine oxidase. Specificity for the two enzyme forms in seven brain regions. Naunyn Schmiedebergs Arch Pharmacol 332: 198–202
Otsaka S, Kobayashi Y (1964) A radioisotopic assay for monoamine oxidase determinations in human plasma. Biochem Pharmacol 13: 995–1006
Parkinson Study Group. DATATOP (1989) A multicenter controlled clinical trial in early Parkinson’s disease. Arch Neurol 46: 1052–1060
Parkinson Study Group. DATATOP (1993) Effects of tocopherol and deprenyl on the progression of disability in early Parkinson’s disease. N Engl J Med 328: 176–183
Polymeropoulos E (1993) 1-Deprenyl: a unique MAO-B inhibitor. In: Szelenyi I (ed) Inhibitors of monoamine oxidase. Birkhäuser, Basel, pp 109–124
Sterling J, Levy R, Veinberg A, Goldenberg W, Finberg J, Youdim MBH, Gutman A (1996) Monofluorinated derivatives of N-propargyl-1-aminoindan and their use as inhibitors of monoamine oxidase. USP 4, 486, 541
Youdim MBH (1995) The advent of selective monoamine oxidase A inhibitor antidepressants devoid of the cheese reaction. Acta Psychiatr Scand 91[Suppl 386]: 5–7
Youdim MBH, Finberg J, Levy R, Sterling J, Lerner D, Berger-Peskin T, Yellin H (1995) R-Enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them. USP 5, 457, 133
Yu P, David B, Boulton A (1992) Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors. J Med Chem 35: 3705–3713
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag Wien
About this paper
Cite this paper
Sterling, J. et al. (1998). (R)(+)-N-Propargyl-1-aminoindan (rasagiline) and derivatives: highly selective and potent inhibitors of monoamine oxidase B. In: Finberg, J.P.M., Youdim, M.B.H., Riederer, P., Tipton, K.F. (eds) MAO — The Mother of all Amine Oxidases. Journal of Neural Transmission. Supplement, vol 52. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6499-0_30
Download citation
DOI: https://doi.org/10.1007/978-3-7091-6499-0_30
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83037-6
Online ISBN: 978-3-7091-6499-0
eBook Packages: Springer Book Archive